Inventor
Kamal Jarrah
Inventor
Prague, CZ
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
C07BGeneral methods of organic chemistry18%
C07CAcyclic or carbocyclic compounds18%
A61KPreparations for medical, dental or toiletry purposes9%
PatentTitleYear
9,862,723'Stable polymorph of the salt of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-α]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-anime with L-tartaric acid'20188,207,356'Method for the preparation of (S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine hydrochloride (duloxetine)'20128,071,791'Method for the preparation of (S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine hydrochloride (duloxetine)'20117,282,517'Method of manufacturing glimepiride and the respective intermediate'2007Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2007Based in Praha, CZ· patent location history
2011–2018Patents assigned to ZENTIVA KS (3)· patent assignee history
2011–2012Patents assigned to CINIBULK JOSEF (2)· patent assignee history
2011–2012Patents assigned to JARRAH KAMAL (2)· patent assignee history
2011–2012Patents assigned to PLACEK LUKAS (2)· patent assignee history
2011–2012Patents assigned to RIDVAN LUDEK (2)· patent assignee history
2011–2018Based in Prague, CZ· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ZENTIVA KS | 3 | 2011–2018 |
| CINIBULK JOSEF | 2 | 2011–2012 |
| JARRAH KAMALself | 2 | 2011–2012 |
| PLACEK LUKAS | 2 | 2011–2012 |
| RIDVAN LUDEK | 2 | 2011–2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Prague, CZ | 3 | 2011–2018 |
| Praha, CZ | 1 | 2007 |